Bristol Myers Squibb BMY
NYSE BMY
$63.03 +0.20 (+0.32%)
At close: Sep 18, 2026 · 4:00 PM EDT

Bristol Myers Squibb (BMY) Dividends Paid - Common (2009 - 2026)

Bristol Myers Squibb's (BMY) quarterly Dividends Paid - Common came in at $1.3 billion in Q2 2026, up 1.98% year-over-year from $1.3 billion in Q2 2025, and little changed quarter-over-quarter from $1.3 billion in Q1 2026.

Analysis

Bristol Myers Squibb (BMY) Dividends Paid - Common (2009 - 2026) Analysis & Trends

Bristol Myers Squibb (BMY) has reported Dividends Paid - Common for 18 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Dividends Paid - Common rose 1.98% year-over-year to $1.3 billion in Q2 2026; TTM through Jun 2026 was $5.1 billion, a 2.85% increase from a year earlier, with the FY2025 full-year figure at $5.0 billion, up 3.74% from the prior year.
  • Dividends Paid - Common was $1.3 billion for Q2 2026 at Bristol Myers Squibb, roughly flat from $1.3 billion in the prior quarter.
  • Over five years, Dividends Paid - Common peaked at $1.3 billion in Q2 2026 and troughed at $12.0 million in Q2 2022.
  • A 5-year average of $1.2 billion and a median of $1.2 billion in 2024 frame the typical range for Dividends Paid - Common.
  • The widest YoY moves for Dividends Paid - Common: up 9875.0% in 2023, down 0.93% in 2023.
  • Over 5 years, Dividends Paid - Common stood at $1.1 billion in 2022, then increased by 1.31% to $1.2 billion in 2023, then increased by 5.0% to $1.2 billion in 2024, then advanced by 3.61% to $1.3 billion in 2025, then rose by 1.98% to $1.3 billion in 2026.
  • The last three Dividends Paid - Common figures came in at $1.3 billion (Q2 2026), $1.3 billion (Q1 2026), and $1.3 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dividends Paid - Common (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn 3.23 Bn
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn 3.07 Bn
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn 2.14 Bn
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -2.87 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn 2.45 Bn
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn 1.29 Bn
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn 6.09 Bn
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.29 Bn
Mar 31, 2026 1.28 Bn
Dec 31, 2025 1.26 Bn
Sep 30, 2025 1.26 Bn
Jun 30, 2025 1.26 Bn
Mar 31, 2025 1.26 Bn
Dec 31, 2024 1.22 Bn
Sep 30, 2024 1.22 Bn
Jun 30, 2024 1.22 Bn
Mar 31, 2024 1.21 Bn
Dec 31, 2023 1.16 Bn
Sep 30, 2023 1.19 Bn
Jun 30, 2023 1.20 Bn
Mar 31, 2023 1.20 Bn
Dec 31, 2022 1.15 Bn
Sep 30, 2022 1.15 Bn
Jun 30, 2022 12.00 Mn
Mar 31, 2022 1.19 Bn
Dec 31, 2021 1.10 Bn
Sep 30, 2021 1.09 Bn